These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 9768717)

  • 1. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart.
    Drexler H; Kästner S; Strobel A; Studer R; Brodde OE; Hasenfuss G
    J Am Coll Cardiol; 1998 Oct; 32(4):955-63. PubMed ID: 9768717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure.
    Stein B; Eschenhagen T; Rüdiger J; Scholz H; Förstermann U; Gath I
    J Am Coll Cardiol; 1998 Nov; 32(5):1179-86. PubMed ID: 9809923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.
    Gauthier C; Leblais V; Kobzik L; Trochu JN; Khandoudi N; Bril A; Balligand JL; Le Marec H
    J Clin Invest; 1998 Oct; 102(7):1377-84. PubMed ID: 9769330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocyte nitric oxide synthase 2 contributes to blunted beta-adrenergic response in failing human hearts by decreasing Ca2+ transients.
    Ziolo MT; Maier LS; Piacentino V; Bossuyt J; Houser SR; Bers DM
    Circulation; 2004 Apr; 109(15):1886-91. PubMed ID: 15037528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An inhibitor of nitric oxide synthase does not increase contraction or beta-adrenoceptor sensitivity of ventricular myocytes from failing human heart.
    Harding SE; Davies CH; Money-Kyrle AM; Poole-Wilson PA
    Cardiovasc Res; 1998 Dec; 40(3):523-9. PubMed ID: 10070493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure.
    Gealekman O; Abassi Z; Rubinstein I; Winaver J; Binah O
    Circulation; 2002 Jan; 105(2):236-43. PubMed ID: 11790707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat.
    Bendall JK; Damy T; Ratajczak P; Loyer X; Monceau V; Marty I; Milliez P; Robidel E; Marotte F; Samuel JL; Heymes C
    Circulation; 2004 Oct; 110(16):2368-75. PubMed ID: 15466641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of myocyte nitric oxide in beta-adrenergic hyporesponsiveness in heart failure.
    Yamamoto S; Tsutsui H; Tagawa H; Saito K; Takahashi M; Tada H; Yamamoto M; Katoh M; Egashira K; Takeshita A
    Circulation; 1997 Mar; 95(5):1111-4. PubMed ID: 9054836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac nitric oxide synthase 1 regulates basal and beta-adrenergic contractility in murine ventricular myocytes.
    Ashley EA; Sears CE; Bryant SM; Watkins HC; Casadei B
    Circulation; 2002 Jun; 105(25):3011-6. PubMed ID: 12081996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inotropic response to beta-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts.
    Gödecke A; Heinicke T; Kamkin A; Kiseleva I; Strasser RH; Decking UK; Stumpe T; Isenberg G; Schrader J
    J Physiol; 2001 Apr; 532(Pt 1):195-204. PubMed ID: 11368026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium.
    Moniotte S; Kobzik L; Feron O; Trochu JN; Gauthier C; Balligand JL
    Circulation; 2001 Mar; 103(12):1649-55. PubMed ID: 11273992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction.
    Hare JM; Loh E; Creager MA; Colucci WS
    Circulation; 1995 Oct; 92(8):2198-203. PubMed ID: 7554202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced inotropic heart response in selenium-deficient mice relates with inducible nitric oxide synthase.
    Gomez RM; Levander OA; Sterin-Borda L
    Am J Physiol Heart Circ Physiol; 2003 Feb; 284(2):H442-8. PubMed ID: 12529255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of endotoxin on human myocardial contractility involvement of nitric oxide and peroxynitrite.
    Flesch M; Kilter H; Cremers B; Laufs U; Südkamp M; Ortmann M; Müller FU; Böhm M
    J Am Coll Cardiol; 1999 Mar; 33(4):1062-70. PubMed ID: 10091837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence against a role of nitric oxide in the indirect negative inotropic-effect of M-cholinoceptor stimulation in human ventricular myocardium.
    Kilter H; Lenz O; La Rosée K; Flesch M; Schwinger RH; Mädge M; Kuhn-Regnier F; Böhm M
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):308-12. PubMed ID: 8584047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase.
    Brunner F; Andrew P; Wölkart G; Zechner R; Mayer B
    Circulation; 2001 Dec; 104(25):3097-102. PubMed ID: 11748107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines and nitric oxide synthase inhibitor as mediators of adrenergic refractoriness in cardiac myocytes.
    Oddis CV; Finkel MS
    Eur J Pharmacol; 1997 Feb; 320(2-3):167-74. PubMed ID: 9059850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of inducible nitric oxide synthase is increased in patients with heart failure due to ischemic disease.
    Ferreiro CR; Chagas AC; Carvalho MH; Dantas AP; Scavone C; Souza LC; Buffolo E; da Luz PL
    Braz J Med Biol Res; 2004 Sep; 37(9):1313-20. PubMed ID: 15334196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nitric oxide synthase inhibition on Basal function and the force-frequency relationship in the normal and failing human heart in vivo.
    Cotton JM; Kearney MT; MacCarthy PA; Grocott-Mason RM; McClean DR; Heymes C; Richardson PJ; Shah AM
    Circulation; 2001 Nov; 104(19):2318-23. PubMed ID: 11696472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction.
    Massion PB; Dessy C; Desjardins F; Pelat M; Havaux X; Belge C; Moulin P; Guiot Y; Feron O; Janssens S; Balligand JL
    Circulation; 2004 Oct; 110(17):2666-72. PubMed ID: 15492314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.